Texas A&M University
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Texas A&M University sits in the top decile of US sponsors by registered trial count (#248 of 15,742 sponsors by registered trial count).
Texas A&M University: 95 sponsored US clinical trials, 22 recruiting.
Texas A&M University sponsors 95 registered US clinical trials on ClinicalTrials.gov, 22 of them currently recruiting, and 66 completed. 2 of these trials are in Phase 3-4 (later-stage) and 6 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Protein Metabolism, with 3 trials.
Top-decile sponsor footprint
Texas A&M University ranks in the top decile of sponsors by registered trial count (#248 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
66 of 69 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (95.7%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
95 total, page 2 of 2
Comparing Fluoride Varnish and Sealant to Prevent White Spots in Orthodontic Patients
NCT04560478
Enhancing Efficacy of Mango Polyphenols in Lean and Obese
NCT04970589
Macronutrient Distribution and Plasma Metabolites to Model Meals Composition
NCT04928872
Fish Oil and HMB Supplementation in COPD
NCT03796455
Effects Of Ingesting An Energy Bar On Performance And Recovery
NCT03704337
Oral Supplement and Acute Resistance Exercise
NCT06801951
AECOPD and Nutritional Supplementation in COPD
NCT06801964
Trial on Oral Appliance Design for Improving Upper Airway Function and Sleep Quality
NCT03219034
Influence of Eggs on Cognitive Performance
NCT06465888
An Examination of a Weight Loss Formula on Health
NCT03395262
Short Chain Fatty Acid Metabolism in COPD
NCT03327181
Cholesterol and Statin in Healthy Adults
NCT02908425
Very Low Calorie Diet Weight Loss
NCT02780206
Omics Profiling of Weight Loss With Bariatric Surgery
NCT02757638
CHF COPD Sip Feed Anabolic Response
NCT02770092
Chronic Obstructive Pulmonary Disorder and Acute Exercise
NCT02780219
Fish Oil T Cell Function
NCT02775084
Metabolic Processes in Adults and Adolescents With Autism Spectrum Disorder
NCT02733120
Methionine Tolerance in Healthy Human Adults
NCT02566434
Metabolism of Ornithine Phenylacetate
NCT03159390
Method To Measure Protein Digestion & Absorption
NCT02065141
Effects of Alpha-lactalbumin Intake on Metabolic and Cognitive Functions in Elderly
NCT02082418
Fat Metabolism in OSA and COPD
NCT02157844
Assessment of a Pre-Workout Dietary Supplement
NCT02952014
Anti-Inflammatory Effects of Mango Polyphenolics in Inflammatory Bowel Disease
NCT02227602
Fat Metabolism Following Chemotherapy in Breast Cancer
NCT01890824
Nutrition Intervention During Chemotherapy
NCT01871350
Absorption and Antioxidant Effects of Polyphenolics From Acai
NCT02227628
Dietary Histone Deacetylase Inhibitors (HDAC)
NCT01543074
RCT Comparing Invisalign and Traditional Orthodontic Treatment
NCT04556448
Nutritional and Functional Changes in Heart Failure and COPD
NCT01787682
Casein Protein and Leucine Supplementation in Chronic Obstructive Pulmonary Disease (COPD)
NCT01734473
The Effect of 2-DeNT Oral Topical Powder on Minor Recurrent Aphthous Ulcer
NCT02142543
Cruciferous Vegetable Intake and Histone Status in Screening Colonoscopy Patients
NCT01344330
Eicosapentaenoic Acid and Protein Modulation to Induce Anabolism in Chronic Obstructive Pulmonary Disease (COPD): Aim 2
NCT01624792
Development Of An Innovative Panel of Methods To Measure Intestinal Macronutrient Digestion, Absorption, and Function
NCT01494909
Effects of Essential Amino Acid Intake on Net Protein Synthesis in Weight-losing Non-small Cell Lung Cancer Patients
NCT01172314
EAA Intake to Optimize Protein Anabolism in COPD
NCT01173354
Arginine Feeding: a Novel Strategy to Improve Protein Metabolism in Cancer and the Response to Surgery
NCT00497380
Curves 30/30 Study
NCT04344821
Hydrolyzed Casein and Whey Protein Supplementation and the Addition of Leucine to Induce Protein Anabolism in Malnourished COPD Patients
NCT01154400
Leucine-enriched Essential Amino Acid Intake to Optimize Protein Anabolism in Children With Cystic Fibrosis
NCT01172301
New Stable Isotope Method to Determine Protein Requirements in Critically Ill Children
NCT01511354
Effects of Glucosamine and Chondroitin Supplementation in Women With Knee Osteoarthritis Participating in an Exercise and Weight Loss Program
NCT01271218
Egg Cholesterol Consumption, Blood Cholesterol and Skeletal Muscle Hypertrophy
NCT00260442
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 5 |
| Phase 2 | 1 |
| Phase 4 | 2 |
Therapeutic Areas
What is open in the Texas A&M University pipeline
22 recruiting of 95 indexed (23% open); 66 completed (69%).
Phase mix: 2 late (III/IV) vs 6 early (I/II) (early-phase heavy).
Top condition: Protein Metabolism (3 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Texas A&M University: open-pipeline peers nationwide
Peers matched on 95 registered trials and 23% open enrollment, not the therapeutic-area sidebar.
Texas A&M University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 95 trials (± recruiting share)
- AdventHealth · 95 trials · 17% recruiting
- Masimo Corporation · 96 trials · 3% recruiting
- University of Mississippi Medical Center · 96 trials · 10% recruiting
- University of Tennessee · 96 trials · 13% recruiting
Sponsors near 23% open enrollment (± trial volume)
- Clemson University · 23% recruiting · 13 trials
- Liberating Technologies · 23% recruiting · 13 trials
- Rahul Aggarwal · 23% recruiting · 13 trials
- Sequenom · 23% recruiting · 26 trials
Related
What to do with this Texas A&M University page
95 registered trials is a research-attention snapshot, not an endorsement of Texas A&M University or any single study.
- 22 of Texas A&M University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Protein Metabolism is the condition Texas A&M University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Protein Metabolism trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Texas A&M University pipeline card: 95 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.